Concomitant parenteral nutrition and systemic cytotoxic therapy in a metastatic colorectal cancer patient
https://doi.org/10.17650/2220-3478-2012-0-3-42-45
Abstract
Pathologic nutrients metabolism presents a severe problem in metastatic colorectal cancer patients, especially those with canceromatosis. A hypermetabolism-catabolism syndrome frequently develops in in patients with progressing canceromatosis. This leads to cachexia anorexia syndrome, which significantly impedes available treatment options. Artificial nutrition allows to improve available treatment in such patients. We present a successful case of concomitant parenteral nutrition and systemic cytotoxic therapy in metastatic colorectal cancer patient with peritoneal canceromatosis.
About the Authors
A. A. Popov
Saint Petersburg Clinical Scientific-and-Practical (Cancer) Center for Specialized Medical Care Types
Russian Federation
Russian Federation
I. L. Chernikovsky
Saint Petersburg Clinical Scientific-and-Practical (Cancer) Center for Specialized Medical Care Types
Russian Federation
Russian Federation
O. L. Fakhrutdinova
Saint Petersburg Clinical Scientific-and-Practical (Cancer) Center for Specialized Medical Care Types
Russian Federation
Russian Federation
E. V. Tkachenko
Saint Petersburg Clinical Scientific-and-Practical (Cancer) Center for Specialized Medical Care Types
Russian Federation
Russian Federation
References
1. Злокачественные новообразования в России в 2009 году (заболеваемость и смертность). Под ред. В.И. Чиссова, В.В. Старинского, Г.В. Петрова. М.: ФГУ «МНИОИ им. П.А. Герцена» МЗ и СР РФ, 2011. 260 с. http://www.oncology.ru/service/statistics/morbidity/2009.pdf
2. Злокачественные новообразования в России в 2008 году (заболеваемость и смертность). Под ред. В.И. Чиссова, В.В. Старинского, Г.В. Петрова. М.: ФГУ «МНИОИ им. П.А. Герцена» Росмедтехнологий, 2010. 256 с.
3. Мерабишвили В.М. Выживаемость онкологических больных. СПб.: Коста, 2011.
4. Беляев А.М., Захаренко А.А., Кондрацов С.А. и др. Комплексное лечение карциноматоза брюшины при колоректальном раке. Medline.ru 2011;12:185-201.
5. Dworzak F., Ferrari P., Gavazzi C. еt al. Effects of cachexia due to cancer on whole
6. body and skeletal muscle protein turnover. Cancer 1998;82(1):42-8.
7. Костюченко А.Л., Костин Э.Д., Курыгин А.А. Энтеральное искусственное питание в интенсивной медицине. СПб.: Специальная литература, 1996.
8. Tisdale MJ. Tumor-host interactions. J Cell Biochem 2004;93(5):871н7.
9. Slaviero K.A., Read J.A., Clarke S.J., Rivory L.P. Baseline nutritional assessment
10. in advanced cancer patients receiving palliative chemotherapy. Nutr Cancer 2003;46:148-57.
11. Мат. III конгресса «Кахексия-2005». Рим, Италия, 2005.
12. Inui A. Cancer anorexia-cachexia syndrome: current issues in research and
13. management. CA Cancer J Clin 2002; 52(2):72-91.
14. Fearon K.C., Voss A.C., Hustead D.S. et al. Definition of cancer cachexia: effect of weight loss, reduced food intake, and systemic inflammation on functional status and prognosis. Am J Clin Nutr 2006; 83(6):1345-50.
15. Gordon J.N., Green S.R., Goggin P.M. Cancer cachexia. QJM 2005;98(11):779-88.
Review
Views:
1198
Email this article 